Ornidazole
Appearance
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Metabolised via the liver, excreted in the Urine and Feces |
Excretion | 85% of single oral dose is elimiated with 5 days - Urine (63%) and Feces (22%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.037.099 |
Chemical and physical data | |
Formula | C7H10ClN3O3 |
Molar mass | 219.625 g·mol−1 |
3D model (JSmol) | |
|
Ornidazole is a drug that cures some protozoan infections. It is used by the poultry industry.
It has been investigated for use in Crohn's disease after bowel resection.[1]
References
- ^ Rutgeerts P, Van Assche G, Vermeire S; et al. (2005). "Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial". Gastroenterology. 128 (4): 856–61. PMID 15825069.
{{cite journal}}
: Explicit use of et al. in:|author=
(help); Unknown parameter|month=
ignored (help)CS1 maint: multiple names: authors list (link)